Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1988-12-19
1991-09-17
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 3166
Patent
active
050495550
ABSTRACT:
The invention pertains to a method and pharmaceutical compositions for treating, preventing or reducing neurodegeneration associated with chronic central nervous system or hypoxic, ischemic and hypoglycemic injury to the central nervous system and for the treatment of anxiety through the use of 2-amino-.omega.-phosphonoalkanoic acids having a cycloalkyl group bridging adjacent carbons on the alkyl chain, their pharmaceutically acceptable salts and derivatives as neuroprotectants and anxiolytics.
REFERENCES:
patent: 4657899 (1987-04-01), Rzeszotarski et al.
patent: 4761405 (1988-08-01), Rzeszotarski et al.
Conti Lisa H.
Ellenberger Suzanne R.
Ferkany John W.
Guzewska Maria E.
Kyle Donald J.
Fabiano Vincent L.
Friedman Stanley J.
Nova Pharmaceutical Corporation
LandOfFree
Antagonists of specific excitatory amino acid receptors as neuro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of specific excitatory amino acid receptors as neuro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of specific excitatory amino acid receptors as neuro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1917292